Stanford University
Stanford, California, 94305, United States
Location status: Recruiting
NCT Number: NCT07339202
The goal of this clinical trial is to evaluate the feasibility of two different preoperative hemodialysis schedules for people with end-stage kidney disease (ESKD) who undergo surgical procedures. The main questions it aims to answer are:
Is it feasible to randomize participants with ESKD undergoing nonemergent surgical procedures to same-day hemodialysis versus no same-day hemodialysis?
Is it safe to randomize participants with ESKD undergoing nonemergent surgical procedures to same-day hemodialysis versus no same-day hemodialysis?
Researchers will compare the two hemodialysis schedules to see if the scheduling and safety profiles are the same.
Participants will:
Answer questions about their health up to 4 weeks before and 4 weeks after the surgical procedure.
Receive hemodialysis on the day of the surgical procedure or not, depending on the study treatment assignment.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Stanford, California, 94305, United States
Location status: Recruiting
Participants will participate in the study for approximately 2 months, including assessment of 30-day postoperative outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hemodialysis treatment prior to the surgical procedure but on the same calendar day as the surgical procedure (typically in the morning prior to the procedure).
No hemodialysis treatment prior to the surgical procedure but on the same calendar day as the surgical procedure.
Time frame: up to 1 day
Time frame: up to 1 day
Stanford University
Other
Acronym: POD-ESKD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06766539
Attention Distribution, Eye-tracking Technology
Hangzhou, Zhejiang, China
View Trial DetailsNCT07655830
HoLEP (Holmium Laser Enucleation of Prostate), Hyperchloremia
View Trial DetailsNCT07310056
Bronchial Neoplasms, Carcinoma, Bronchogenic
View Trial DetailsNCT07676786
Cardiovascular Diseases, Chronic Disease
Bucharest, Romania
View Trial Details